LAKE SUCCESS, NY -- The North Shore-LIJ Cancer Institute announced today that its Breast Cancer Centers at both North Shore University Hospital (NSUH) and Long Island Jewish (LIJ) Medical Center have been granted three-year, full accreditation by the American College of Surgeons' National Accreditation Program for Breast Centers (NAPBC).
“This recognition is a gratifying acknowledgement of the well-organized, interdisciplinary breast program we have developed at North Shore University Hospital and LIJ Medical Center," said Lora Weiselberg, MD chief of the breast cancer service at the North Shore-LIJ Cancer Institute. “Our program reflects the cooperative spirit and dedication of our team of surgeons, radiologists, radiation oncologists, medical oncologists, pathologists, nurses, rehabilitation medicine specialists, nutritionists, social workers and administrators.”
Both NSUH and LIJ are also recipients of the American College of Surgeons’ Commission on Cancer’s Outstanding Achievement Award, which recognizes cancer programs that strive for excellence in providing quality care.
Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest of quality breast care and undergo a rigorous evaluation and review of their performance. Receiving care at a NAPBC-accredited center ensures that patients have access to comprehensive care, including a full range of services, a multidisciplinary team approach to coordinate the best treatment options, information about ongoing clinical trials, new treatment options and quality breast care close to home.
During the survey process, the center must demonstrate compliance with standards established by the NAPBC for treating women diagnosed with the full spectrum of breast disease. The standards include proficiency in the areas of: center leadership, clinical management, research, community outreach, professional education and quality improvement. Breast centers that achieve NAPBC accreditation demonstrate a firm commitment to offering patients significant advantages in their battle against breast disease.
To maintain accreditation, centers must monitor compliance with NAPBC standards to ensure quality care and undergo an on-site review every three years.
The NAPBC is a consortium of national, professional organizations dedicated to the improvement of the quality of care and the monitoring of outcomes for patients with diseases of the breast. The NAPBC Board defined 28 program standards and 17 program components of care that collectively provide the most efficient and contemporary care available for patients diagnosed with diseases of the breast.
The American Cancer Society (ACS) estimated that there would be 232,340 patients diagnosed with invasive breast cancer in the United States in 2013. In addition, hundreds of thousands of women who will deal with benign breast disease this year will require medical evaluation for treatment options.
About North Shore-LIJ Cancer Institute
The North Shore-LIJ Cancer Institute offers inpatient services at North Shore University Hospital (NSUH), LIJ Medical Center, Cohen Children’s Medical Center, Glen Cove, Huntington, Southside, Lenox Hill, Staten Island University, Plainview, Forest Hills and Franklin hospitals. Outpatient services are available at the Monter Cancer Center in Lake Success, NY, LIJ Medical Center, Cohen Children’s Medical Center, Glen Cove, Lenox Hill and Staten Island University hospitals, and physician offices throughout Queens, Long Island, Staten Island and Manhattan.
With approximately 150 physicians, the Cancer Institute is comprised of 12 centers of excellence focused on: brain tumors, breast cancer, cancer genetics, gastrointestinal oncology, gynecologic oncology, head and neck oncology, hematologic oncology, lung cancer, melanoma and rare skin cancer, supportive oncology and pain management, pediatric hematology/oncology, and prostate and genitourinary cancer. The Cancer Institute and its physicians are involved in more than 175 cancer clinical trials and have accumulated 30 years of experience in National Cancer Institute-sponsored clinical research.
Media Contact: Elaine Wohl